> Jazz Pharmaceuticals announced that Xyrem (sodium oxybate) oral solution has been approved for marketing by the FDA to treat excessive daytime sleepiness in patients with narcolepsy. Release
> A new study of 10,000 patients found that patients taking either low-molecular-weight heparin (enoxaparin) or unfractionated heparin were equally effective in reducing death or heart attack. Report
> AstraZeneca says it will sue Ranbaxy over its challenge to the patent for the ulcer drug Nexium. Report
> Canada's Neurochem has begun enrolling patients for a Phase III trial of its Alzheimer's therapy Alzhemed. Report
> Tripos announced that its file enrichment collaboration with Pfizer will conclude in December 2005. Release
And Finally… Economist Robert Samuelson says that the new Medicare drug benefit is a calamity as government policy. Column